Primary care-based disease management of chronic kidney disease (CKD), based on estimated glomerular filtration rate (eGFR) reporting, improves patient outcomes

Nephrology Dialysis Transplantation

Volumn 23, Issue 2, 2008, Pages 549-555

  Richards, Nick ^a   Harris, Kevin ^b   Whitfield, Malcolm ^c   O'Donoghue, Donal ^d   Lewis, Robert ^e   Mansell, Martin ^f   Thomas, Stephen ^g   Townend, John ^h   Eames, Mick ⁱ   Marcelli, Daniele ^j  

^a Fresenius Medical Care Renal Service Ltd   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

^d HOPE HOSPITAL   (United Kingdom)

^e QUEEN ALEXANDRA HOSPITAL   (United Kingdom)

^f ROYAL FREE HOSPITAL   (United Kingdom)

^g ST THOMAS HOSPITAL   (United Kingdom)

^h UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

ⁱ The Surgery   (United Kingdom)

^j FRESENIUS MEDICAL CARE   (Germany)

more..

Author keywords

Cardiovascular risk; CKD; Disease management; eGFR; Progression

Indexed keywords

ARTICLE; BLOOD PRESSURE REGULATION; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; FEMALE; GLOMERULUS FILTRATION RATE; HEALTH PROGRAM; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; TREATMENT OUTCOME;

AGED; CHRONIC DISEASE; FEMALE; GLOMERULAR FILTRATION RATE; GREAT BRITAIN; HUMANS; KIDNEY DISEASES; MALE; PRIMARY HEALTH CARE; TREATMENT OUTCOME;

EID: 44449179800     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfm857     Document Type: Article

References (50)

1. Schoolwerth AC, Engelgau MM, Hostetter TH et al. Chronic kidney disease: a public health problem that needs a public health action plan. Prev Chronic Dis 2006; 3: 1-6
2. Coresh J, Astor BC, Greene T et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003; 41: 1-12
3. Levey AS, Bosch JP, Lewis JB et al. (Modification of Diet in Renal Disease Study Group). A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999; 130: 461-470
4. El Nahas AM, Bello AK. Chronic kidney disease: the global challenge. Lancet 2005; 365: 331-340
5. de Lusignan S, Chan T, Stevens P et al. Identifying patients with chronic kidney disease from general practice computer records. Fam Pract 2005; 22: 234-241
6. NHS Employers. Contract changes for 2006/07. 2006 www.nhsemployers.org/ primary/primary-2450.cfm
7. de Lusignan S. Chronic kidney disease: a new priority for primary care. B J Gen Pract 2006; 56: 908-910
8. Ansell D, Byrne Feest T, Ahmad A. 6th Annual Report, UK National Renal Registry, 2003, 339-344
9. Stevens PE, O'Donoghue DJ, de Lusignan S et al. Chronic kidney disease management in the United Kingdom: NEOERICA project results. Kidney Int 2007; (72)1: 92-99
10. Keith DS, Nichols GA, Gullion CM et al. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organisation. Arch Intern Med 2004; 164: 659-663
11. Spence D. Who put CKD in the new GP contract? BMJ.com 2006; 8 November
12. Giles PD, Fitzmaurice DA. Formula estimation of glomerular filtration rate: have we gone wrong? BMJ 2007; 334: 1198-1200
13. Chen RA, Scott S, Mattern WD et al. The case for disease management in chronic kidney disease. Dis Manag 2006; 9: 86-92
14. Wrone EM, Hornberger J. Evaluating the consequences of multidisciplinary case management for patients with chronic renal failure. Am J Med 1998; 105: 546-548
15. Nissenson AR, Collins AJ, Dickmeyer J et al. Evaluation of disease-state management of dialysis patients. Am J Kidney Dis 2001; 37: 938-944
16. Roderick P, Jones C, Tomson C et al. Late referral for dialysis: improving the management of chronic renal disease QJM 2002; 95: 363-370
17. Foley RN, Parfrey PS. Cardiovascular disease and mortality in ESRF. K Nephrol 1998; 11: 239-245
18. Henry RM, Kostense PJ, Bos G et al. Mild renal insufficiency is associated with increased cardiovascular mortality: the Hoorn Study. Kidney Int 2002; 62: 1402-1407
19. Drey N, Roderick P, Mullee M et al. A population-based study of the incidence and outcomes of diagnosed chronic kidney disease. Am J Kidney Dis 2003; 42: 677-684
20. Trivedi HS, Pang MMH, Campbell A et al. Slowing the progression of chronic renal failure: economic benefits and patients' perspectives. Am J Kidney Dis 2002; 39: 721-729
21. Joint Speciality Committee for Renal Disease of the Royal College of Physicians of London and the Renal Association. Chronic Kidney Disease in Adults; UK Guidelines for Identification, Management and Referral. Royal College of Physicians of London, 2006
22. Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness: the chronic care model, part 2. JAMA 2002; 288: 1909-1914
23. Wagner EH, Austin BT, Davis C et al. Improving chronic illness care: translating evidence into action. Health Aff 2001; 20: 64-78
24. Black DA Case management for elderly people in the community BMJ 2007; 334: 3-4
25. Gravelle H, Dusheiko M, Sheaff R et al. Impact of case management (Evercare) on frail elderly patients: controlled before and after analysis of quantitative outcome data. BMJ 2007; 334: 31-36
26. Winkelmeyer WC, Schneeweiss S, Mogun H et al. Identification of individuals with CKD from Medicare claims data: a validation study. Am J Kidney Dis 2005; 46: 225-232
27. Schmidt RJ, Domico JR, Sorkin MI et al. Early referral and its impact on emergent first dialysis, health care costs and outcome. Am J Kidney Dis 1998; 32: 278-283
28. Anand S, Nissenson AR. Utilising a disease management approach to improve ESRD patient outcomes. Semin Dial 2002; 15: 38-40
29. Harris LE, Luft FC, Ruddy DW et al. Effects of multidisciplinary case management in patients with chronic renal insufficiency. Am J Med 1998; 105: 464-471
30. Go AS, Chertow GM, Fan D et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305
31. Anavekar NS, Pfeffer MA. Cardiovascular risk in chronic kidney disease. Kidney Int Suppl 2004; 66: S11-S15
32. Baigent C, Burbury K, Wheeler D. Premature cardiovascular disease in chronic renal failure. Lancet 2000; 356: 147-52
33. Lazarus JM, Bourgoignie JJ, Buckalew VM et al. (The Modification of Diet in Renal Disease Study Group). Achievement and safety of a low blood pressure goal in chronic renal disease. Hypertension 1997; 29: 641-650
34. Perkovic, V, Ninomiya, T, Arima, H et al. Chronic kidney disease, cardiovascular events, and the effects of perindopril-based blood pressure lowering: data from the PROGRESS Study. J Am Soc Nephrol 2007; 18: 2766-2767
35. Sarnak MJ, Greene T, Wang X et al. The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study. Ann Intern Med 2005; 142: 342-351
36. Wright JT Jr, Bakris G, Greene T et al. (African American Study of Kidney Disease and Hypertension Study Group).Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA 2002; 288: 2421-2431
37. Chobanian AV, Bakris GL, Black HR et al. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206-1252
38. Neal B, MacMahon S, Chapman N (Blood Pressure Lowering Treatment Trialists' Collaboration). Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Lancet 2000; 356: 1955-1964
39. Sever PS, Dahlof B, Poulter NR et al. (ASCOT investigators). Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial - Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet 2003; 361: 1149-1158
40. Tonelli M, Isles C, Curhan GC et al. Effect of pravastatin on cardiovascular events in people with chronic kidney disease. Circulation 2004; 110: 1557-1563;
41. Department of Health. National Service Framework for Renal Services - Part 2: Chronic Kidney Disease, Acute Renal Failure and End of Life Care. London: Crown copyright, 2005
42. LaRosa JC, Grundy SM, Waters DD et al. (Treating to New Targets (TNT) Investigators). Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med 2005; 352: 1425-1435
43. Wanner C, Krane V, Marz W et al. (Diabetes and Dialysis Study Investigators). Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 2005; 353: 238-248
44. Mitch WE, Walser M, Buffington GA et al. A simple method of estimating progression of chronic renal failure. Lancet 1976; 2: 1326-1328
45. Klahr S, Schreiner G, Ichikawa I. The progression of renal disease. N Engl J Med 1988; 318: 1657-1666
46. Serrano A, Huang J, Ghossein C et al. Stabilisation of glomerular filtration rate in advanced chronic kidney disease: a two year follow-up of a cohort of chronic kidney disease patients stages 4 and 5. Adv in Chronic Kidney Dis 2007; 14: 105-112
47. Jaber BL, Madias NE. Progression of chronic kidney disease: can it be prevented. Am J Med 2005; 118: 1323-1330
48. Feringa HHH, Karagiannis SE, Chonchol M et al. Lower progression rate of endstage renal disease in patients with peripheral vascular disease using statins or angiotensin-converting enzyme inhibitors. J Am Soc Nephrol 2007; 18: 1872-1879
49. Neyman J. Statistics: servant of all sciences. Science 1955; 122: 401-406
50. Wickstrom G, Bendix T. The Hawthorne effect - what did the original Hawthorne studies actually show? Scand J Work Environ Health 2000; 26: 363-367